The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors
Clinical trial NCT04768868 · UNKNOWN
Trial details
- NCT number
- NCT04768868
- Sponsor
- Impact Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2023-04-30
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.